Cross-talk between SIM2s and NFkB regulates cyclooxygenase 2 expression in breast cancer
G. L. Wyatt, C. Young, L. Crump, V. Wessells, T. Gustafson, Y.-Y. Fan, R. Chapkin, W. Porter, T. R. Lyons
This study shows that SIM2s inhibits NFkB activation and COX-2 expression in breast cancer, suggesting a potential therapeutic target.
bioRxiv · May 10, 2019Cancer Biology